Edition:
United Kingdom

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329.SS)

600329.SS on Shanghai Stock Exchange

13.42CNY
16 Oct 2018
Change (% chg)

¥-0.37 (-2.68%)
Prev Close
¥13.79
Open
¥13.86
Day's High
¥13.98
Day's Low
¥13.19
Volume
3,800,120
Avg. Vol
6,892,410
52-wk High
¥22.34
52-wk Low
¥12.51

Latest Key Developments (Source: Significant Developments)

Zhongxin Information Development Inc Ltd Shanghai says dividend payment date on July 4
Thursday, 28 Jun 2018 

June 28(Reuters) - Zhongxin Information Development Inc Ltd Shanghai <300469.SZ>:Says it will pay a cash dividend of 1.00 yuan (before tax) per 10 shares and use additional paid-in capital to distribute 8 new shares for every 10 shares for FY 2017, to shareholders of record on July 3 .Says the company's shares will be traded ex-right and ex-dividend on July 4 and the dividend will be paid on July 4.  Full Article

Tianjin Zhongxin Pharmaceutical Group unit receives GMP certificate
Friday, 25 May 2018 

May 25 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> ::* Says its controlling unit received goods manufacture practice (GMP) certificate from Tianjin Food and Drug Administration .* Certificate issued cephalosporins powder-injection manufactured by the unit and valid period is until Dec. 12, 2022.  Full Article

Tianjin Zhongxin Pharmaceutical Group Corp Posts Q1 Profit Of RMB174.1 Mln
Friday, 27 Apr 2018 

April 27 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::QTRLY PROFIT, NET OF TAX RMB174.1 MILLION VERSUS RMB133.3 MILLION.Q1 REVENUE RMB1.62 BILLION VERSUS RMB1.48 BILLION.  Full Article

Tianjin Zhongxin Pharmaceutical Says FY Profit Net Of Tax Attributable Rmb476.1 Million
Friday, 30 Mar 2018 

March 30 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::FY REVENUE RMB5.69 BILLION VERSUS RMB6.24 BILLION.FY PROFIT NET OF TAX ATTRIBUTABLE RMB476.1 MILLION VERSUS RMB423.6 MLN‍​.  Full Article

Tianjin Zhongxin Pharmaceutical says qtrly ‍revenue was down 14​ percent
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::Qtrly ‍revenue RMB1.31 billion, down 14​ percent.Qtrly profit, net of tax attributable RMB82 million versus RMB91.6 mln‍​.  Full Article

Tianjin Zhongxin Pharmaceutical Group appoints Li Li Qun as chairman​
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:‍Resolution passed to appoint Li Li Qun as chairman​.  Full Article

CORRECTED-China, HK stocks fall ahead of Sino-U.S. trade talks

SHANGHAI, May 2 China stocks, which resumed trading after the Labour Day holiday, fell on Wednesday morning, as investors braced for trade talks between U.S. and Chinese officials amid concerns over economic growth. Hong Kong shares were also down.